Medianvarigheden af førstevalgsbehandling var henholdsvis 60 og 8 måneder i Glivec - og INF - armene fem år, efter at den sidste patient var rekrutteret.
Five years after the last patient had been recruited, the median duration of first-line treatment was 60 and 8 months in the Glivec and IFN arms, respectively.